Polyrizon (PLRZ) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Polyrizon (PLRZ) is Moderate Underperform.

The composite score behind that read is -0.42, weighing +0.05 of bullish evidence against -0.47 bearish.

Polyrizon last closed at $9.67, +4.43% on the session.

Against the IVW growth benchmark the position is +3.82% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

17 graded predictions for PLRZ so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Polyrizon is classified under Health Care / Biotechnology, with a market capitalisation of $21.96M.

StockMap tracks Polyrizon as the 319th largest of the 365 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 190 Moderate Underperform, 164 Neutral and 11 Strong Underperform.

On that composite Polyrizon ranks 336th of 365 in the group, against a group median of -0.21.